U.S. Basic Materials Stock News

Edwards Lifesciences reported its second-quarter 2026 results in July, with sales rising to US$1,741 million from US$1,532.2 million a year earlier, while net income and earnings per share declined, and the company issued third-quarter guidance for total sales of US$1.63 billion to US$1.71 billion. Alongside these results, Edwards Lifesciences raised its full-year 2026 sales growth guidance, including higher targets for its TAVR and TMTT product groups, signaling management’s increased...

NOV Inc. has reported its second-quarter 2026 results, with revenue of US$2,134 million versus US$2,188 million a year earlier, net income of US$112 million versus US$108 million, and has guided third-quarter consolidated revenue to be flat to up 2% year over year. Alongside slightly lower sales, NOV grew quarterly earnings per share and continued executing its buyback, retiring 3,200,000 shares for US$63 million in the latest tranche. Next, we'll examine how NOV's combination of modest...

Innodata (INOD) has drawn fresh attention after record revenue growth and an expanded earnings outlook highlighted its role in AI data engineering. New platform offerings and broader customer demand are now central to the latest move in the stock. See our latest analysis for Innodata. Despite the strong business update, Innodata’s recent share price momentum has cooled, with the stock down 22.11% over the past month but still showing a 44.08% 90 day share price return and a very large 5 year...

United Airlines Holdings (UAL) has moved back into focus after issuing tighter earnings guidance for 2026 and the third quarter, tying its outlook to higher oil prices and a shifting operating backdrop. See our latest analysis for United Airlines Holdings. United Airlines Holdings shares have been volatile, with a 2.65% 1 day share price return and 5.55% 7 day share price return, set against a 30 day share price decline of 8.45% and a 37.52% 90 day share price return. The 1 year total...

Over the last 7 days, the United States market has experienced a 1.5% decline, yet it has shown resilience with a 16% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider activity could offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends.

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In such an environment, growth stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential for significant revenue expansion.

Over the last 7 days, the United States market has dropped 1.5%, yet it remains up 16% over the past year, with earnings anticipated to grow by 17% per annum in the coming years. In such a landscape, identifying stocks with strong financials is crucial for investors seeking opportunities beyond traditional large-cap investments. Penny stocks, despite their somewhat outdated moniker, continue to intrigue investors due to their potential for value and growth; we'll explore several that stand...

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it has risen by 16% over the past year with earnings forecast to grow by 17% annually. In this dynamic environment, reliable dividend stocks can offer investors a steady income stream and potential for capital appreciation.

Anyone interested in Olema Pharmaceuticals, Inc. ( NASDAQ:OLMA ) should probably be aware that the Independent...

The fact that multiple Oculis Holding AG ( NASDAQ:OCS ) insiders offloaded a considerable amount of shares over the...

Kinder Morgan, Inc. ( NYSE:KMI ) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day...

Even though Allogene Therapeutics, Inc. ( NASDAQ:ALLO ) has fallen by 10% over the past week , insiders who sold...

As you might know, Las Vegas Sands Corp. ( NYSE:LVS ) last week released its latest second-quarter, and things did not...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Whilst it may not be a huge deal, we thought it was good to see that the Oak Valley Bancorp ( NASDAQ:OVLY ) Independent...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

We wouldn't blame Weatherford International plc ( NASDAQ:WFRD ) shareholders if they were a little worried about the...

Anyone interested in First United Corporation ( NASDAQ:FUNC ) should probably be aware that the Executive VP & Chief...

Consumer staples often sit quietly in portfolios while headlines focus on airlines, tech giants, and swings in oil prices. Yet when companies like Coca-Cola beat earnings expectations and raise their outlook, it can draw attention back to dependable dividend payers. With recent results from Boeing, JetBlue, UPS, and sharp moves in Brent oil creating fresh cross-currents for markets, this article looks at three large, established consumer staples stocks from our defensive dividend screener...

Centene stock barely flinched after earnings, slipping only 0.3% to about US$63.90, even though the headline numbers packed far more punch than that move suggests. The insurer lifted full year adjusted earnings per share guidance to more than US$4.80 and posted Q2 adjusted EPS of US$2.51, powered in part by risk adjustment settlements. For a company still wrestling with unprofitable trailing twelve month results, that kind of earnings power and guidance reset is the real story. The modest...

Xylem shares opened the morning after earnings up about 4% at US$124.97, a strong move for a steady water technology stock that usually trades on long contracts rather than headlines. The market is reacting to one clear message: profitability is the story this quarter. Record quarterly earnings per share of US$1.46 and an adjusted EBITDA margin of 23.3% put the focus firmly on margins rather than modest top line growth. For investors thinking beyond today’s bounce, the question now is how...

UnitedHealth Group has delivered a strong 68.6% return over the past year, yet its valuation checks point to a more mixed picture rather than a clear bargain or an obviously stretched stock. Over the last 12 months, the stock is up 68.6%, which puts recent buyers in a comfortable position and raises the bar for what counts as good value from here. Recent coverage has highlighted improved profitability and operational efficiencies as potential supports for earnings, while ongoing shifts in...

Liberty Latin America stock has delivered a 24.0% gain over the past year but is still down 37.7% over five years, which raises the question of whether the recent recovery is finally bringing the share price closer to what its fundamentals suggest. Over the last five years the stock has declined 37.7%, which indicates long term holders have not yet recovered from earlier share price weakness. The recent agreement to sell its stake in Peru based WOW Tel S.A.C. can help Liberty Latin America...